British medical bulletin · 2016
Bioethics meets Ebola: exploring the moral landscape.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Thompson Alison K
Аннотация
INTRODUCTION: The Ebola Virus Disease (EVD) outbreak in West Africa raised ethical issues about structural disadvantage; the duty to care of healthcare workers; the use and study of unregistered agents; the use of restrictive measures like mass quarantine and the importance of public trust.
SOURCES OF DATA: WHO reports, literature on EVD and ethics.
AREAS OF AGREEMENT: The use of restrictive measures and the testing of unregistered agents is ethical if support for individuals or communities is provided.
AREAS OF CONTROVERSY: Controversy exists over ethical trial design for the study of unregistered agents and over the limits of the duty to care.
GROWING POINTS: The role of the WHO in outbreak control and research oversight needs rethinking and further support. Solidarity in global health needs fostering.
AREAS TIMELY FOR DEVELOPING RESEARCH: Research is needed on how to restore and enhance health systems and public trust in EVD-affected countries.
SOURCES OF DATA: WHO reports, literature on EVD and ethics.
AREAS OF AGREEMENT: The use of restrictive measures and the testing of unregistered agents is ethical if support for individuals or communities is provided.
AREAS OF CONTROVERSY: Controversy exists over ethical trial design for the study of unregistered agents and over the limits of the duty to care.
GROWING POINTS: The role of the WHO in outbreak control and research oversight needs rethinking and further support. Solidarity in global health needs fostering.
AREAS TIMELY FOR DEVELOPING RESEARCH: Research is needed on how to restore and enhance health systems and public trust in EVD-affected countries.